title: Endocarditis due to Yersinia enterocolitica.
authors.forename: E
authors.initials: E
authors.lastname: Bonnet
authors.forename: M
authors.initials: M
authors.lastname: Archambaud
authors.forename: A
authors.initials: A
authors.lastname: Sommabere
authors.forename: C
authors.initials: C
authors.lastname: Suc
authors.forename: Z
authors.initials: Z
authors.lastname: Elias
authors.forename: M
authors.initials: M
authors.lastname: Gallinier
authors.forename: P
authors.initials: P
authors.lastname: Massabuau
authors.forename: J P
authors.initials: JP
authors.lastname: Bounhoure
authors.forename: P
authors.initials: P
authors.lastname: Massip
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009428:Netilmicin / Q000627:therapeutic use; D015009:Yersinia Infections / Q000188:drug therapy / Q000382:microbiology*; D015008:Yersinia enterocolitica / Q000187:drug effects / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D005839:Gentamicins; D009428:Netilmicin; D002939:Ciprofloxacin